Emergent Biosolutions EBS Treasury stock, shares (in shares)
Treasury stock, shares (in shares) at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's treasury stock, shares (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's treasury stock, shares (in shares)?
- Emergent Biosolutions (EBS) reported treasury stock, shares (in shares) of $9.6M in Q1 2026.
- How has Emergent Biosolutions's treasury stock, shares (in shares) changed year-over-year?
- Emergent Biosolutions's treasury stock, shares (in shares) increased by 71.4% year-over-year, from $5.6M to $9.6M.
- What is the long-term trend for Emergent Biosolutions's treasury stock, shares (in shares)?
- Over 3 years (2022 to 2025), Emergent Biosolutions's treasury stock, shares (in shares) has grown at a 15.8% compound annual growth rate (CAGR), from $5.6M to $8.7M.